000 01350 a2200421 4500
005 20250515123116.0
264 0 _c20080707
008 200807s 0 0 eng d
022 _a0301-0430
024 7 _a10.5414/cnp69347
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChen, H-H
245 0 0 _aIncreased erythropoietin-alpha dose when switching from subcutaneous to intravenous administration: effect of serum albumin.
_h[electronic resource]
260 _bClinical nephrology
_cMay 2008
300 _a347-53 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aEpoetin Alfa
650 0 4 _aErythropoietin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aFerritins
_xblood
650 0 4 _aHematocrit
650 0 4 _aHumans
650 0 4 _aInjections, Intravenous
650 0 4 _aInjections, Subcutaneous
650 0 4 _aKidney Failure, Chronic
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRecombinant Proteins
650 0 4 _aRenal Dialysis
650 0 4 _aSerum Albumin
_xanalysis
650 0 4 _aTransferrin
_xanalysis
700 1 _aTarng, D-Ch
700 1 _aWu, Ch-J
700 1 _aChen, Y-W
700 1 _aTing, J-T
773 0 _tClinical nephrology
_gvol. 69
_gno. 5
_gp. 347-53
856 4 0 _uhttps://doi.org/10.5414/cnp69347
_zAvailable from publisher's website
999 _c18023929
_d18023929